L. T. Alimkhodjaeva, O. M. Akhmadjanova, S. S. Ziyavidenova
Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology, Tashkent, Uzbekistan
Copyright © 2026 The Author(s). Published by Scientific & Academic Publishing.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/

Abstract
The aim of the study was to improve the prognosis and treatment outcomes for patients with infiltrating breast cancer by improving modern methods of molecular genetic diagnostics. Background. Breast cancer remains one of the major challenges in both basic and clinical oncology, as its incidence remains the highest among malignant tumors in women. Despite significant advances in the early diagnosis and treatment of breast cancer, the mortality rate from the disease continues to be high and is showing a persistent upward trend. Currently, the prevalence of infiltrating breast cancer remains unclear, as evidenced by the wide range of incidence rates reported by various authors—from 2 to 62 percent. Material and Methods. This study was conducted at the Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology and all its branches between 2020 and 2024. The research material consisted of 128 tumor tissue biopsy samples, retrieved from the archives, from patients undergoing treatment for breast cancer. Results. Among the primary structures of the tumor’s parenchymal component, we identified large- and small-alveolar, trabecular, cribriform, and tubular structures. The frequency distribution of these structures varied significantly depending on the histological subtype of breast cancer. For instance, trabecular structures were the most common feature in cases of invasive lobular carcinoma, accounting for 89% of all observed structures, whereas they were entirely absent in cases of invasive ductal carcinoma. Conclusion. Thus, overall, it can be concluded that the invasive ductal carcinoma variant of breast cancer, based on its microscopic features, is characterized by a statistically significantly higher degree of malignancy, higher mitotic activity of tumor cells, a higher degree of inflammatory infiltration of the stromal component, and the presence of cribriform structures and necrotic processes in the parenchyma. The invasive lobular carcinoma variant of breast cancer is characterized by pronounced stromal hyalinosis and infiltration of adipose tissue, a predominance of trabecular structures in the parenchyma, and the presence of “dark” cells.
Keywords:
Breast cancer, Infiltrating breast cancer, Invasive lobular carcinoma, Invasive ductal carcinoma
Cite this paper: L. T. Alimkhodjaeva, O. M. Akhmadjanova, S. S. Ziyavidenova, Key Features of Tumor with an Infiltrative Growth Pattern for Breast Cancer, Research In Cancer and Tumor, Vol. 13 No. 2, 2026, pp. 30-33. doi: 10.5923/j.rct.20261302.03.
1. Introduction
Breast cancer (BC) remains one of the major challenges in both basic and clinical oncology, as its incidence remains the highest among malignant tumors in women [1-3]. There has been rapid progress in understanding the fundamental mechanisms underlying the development and growth of these tumors recently. Despite significant advances in the early diagnosis and treatment of breast cancer, the mortality rate from the disease continues to be high and is showing a persistent upward trend [1,4-5]. The study of the morphological mechanisms underlying the origin and development of tumors has been and remains a pressing challenge in medicine and requires the use of modern research and treatment methods to address both theoretical and practical issues in oncology. Currently, the prevalence of infiltrating breast cancer remains unclear, as evidenced by the wide range of incidence rates reported by various authors—from 2 to 62 percent (Semiglazov V.F..., 2016; Vlastos G. et al., 2000). Issues related to the diagnosis, selection of appropriate treatment, and prognosis of infiltrating breast cancer remain particularly challenging. Findings on the prognostic significance of infiltrating breast cancer cells are controversial. Some authors point out that true primary resistance does not affect the prognosis and occurs with equal frequency in patients with both favorable and unfavorable disease outcomes; other researchers consider multifocal tumor growth to be one of the most significant factors determining the risk of disease recurrence [6-8]. There is no consensus regarding the extent of lymphatic metastasis in this form of breast cancer. Infiltrating breast cancer is a significant problem largely due to the characteristics of its clinical course, the lack of clear criteria for preoperative diagnosis, insufficient information regarding its prognostic significance, and the need to select optimal treatment methods, particularly breast-conserving surgeries. [9-10].The aim of the study was to improve the prognosis and treatment outcomes for patients with infiltrating breast cancer by improving modern methods of molecular genetic diagnostics.
2. Material and Methods
General characteristics of infiltrating breast cancer clinical observationsThis study was conducted at the Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology and all its branches between 2020 and 2024. The research material consisted of 128 tumor tissue biopsy samples, retrieved from the archives, from patients undergoing treatment for breast cancer. In addition to biopsy specimens, the analysis included medical history, clinical and laboratory data, and other materials from the medical records of the patients mentioned above. We analyzed primary documents such as medical records and outpatient charts of the patients. Based on data obtained from medical records and in accordance with the study’s objectives and goals, we analyzed microscopic specimens of infiltrating breast cancer by examining the following data from the patients’ medical records:- age;- clinical stage of the disease;- results of immunohistochemical analysis of tumor tissue for the expression of estrogen, progesterone, and HER-2neu receptors.As part of their combination therapy, all patients underwent 8 courses of preoperative chemotherapy using the CAF regimen (Adriamycin 30 mg/m² IV, on days 1 and 8, 5-fluorouracil 500 mg/m² IV on days 1 and 8, and cyclophosphamide 100 mg/m² IM on days 1 and 8), followed by surgical intervention consisting of organ-preserving and radical mastectomy. During the postoperative period, patients received adjuvant chemotherapy based on medical indications and their clinical condition. antiestrogen therapy with tamoxifen and distant gamma therapy to the regional lymphatic drainage areas were administered based on clinical indications. In cases of HER2/neu-positive status, targeted therapy with Herceptin was additionally administered.The diagnosis of breast cancer was established according to the “Histological Classification of Breast Tumors” (WHO, 2003). The tumor was classified as either infiltrating lobular carcinoma or ductal carcinoma. A diagnosis of infiltrating ductal carcinoma was established in 118 (88.7%) patients, infiltrating lobular carcinoma - in 8 (6.0%) patients, and other forms (mucinous, solid, medullary) - in 7 (5.3%) cases. Infiltrating ductal carcinoma, which occurred in 88.7% of cases, was predominantly of histological grade 2 and was the most common type across all study groups. The patient groups studied were comparable in terms of key clinical and morphological parameters. The surgical specimens were subjected to morphological examination. Sample tissues were placed in a fixative solution—neutral formalin. The specimens were processed according to standard procedures and embedded in paraffin. Sections 5–6 µm thick were stained with hematoxylin and eosin. Morphological examination was performed using a light microscope manufactured by “Carl Zeiss Microimaging,” (Germany). The center and periphery of macroscopically detectable tumor nodules, breast tissue from the four quadrants outside the tumor, and all axillary lymph nodes were evaluated. The center and peripheral regions of the tumor mass were examined, and the ductal structures and infiltrative component were assessed. Within the tumor ducts, solid, cribriform, and papillary structures were identified. In the infiltrative component, trabecular, tubular, microalveolar, solid, and cribriform structures and separate small clusters of tumor cells were identified. Parenchymal structures were assessed using a semiquantitative method based on a 5-point scale (from 1 to 5). In addition, each of the four quadrants of the breast was examined for the presence of possible tumor microfoci. The condition of all axillary lymph nodes was assessed (from 3 to 45 lymph nodes were examined). Metastases were noted.The data obtained were analyzed using the “Statistica 6.0 for Windows” software package. The Student’s t-test for dependent and independent samples, the Mann-Whitney U test, and analysis of variance (ANOVA) were used.
3. Results
To identify differences in the morphological characteristics of tumor tissue from different histological subtypes of invasive breast cancer, all parameters used in the histological description were divided into two groups. The first group consisted of qualitative nominal characteristics, which included the frequencies of the main structures of the parenchymal component and the main structures invading the stroma of the tumor nodule at the periphery. All other descriptive histological parameters were classified as semi-quantitative, and their severity was evaluated on a point scale. Among the primary structures of the tumor’s parenchymal component, we identified large- and small-alveolar, trabecular, cribriform, and tubular structures. The frequency distribution of these structures varied significantly depending on the histological subtype of breast cancer. For instance, trabecular structures were the most common feature in cases of invasive lobular carcinoma (ILC), accounting for 89% of all observed structures, whereas they were entirely absent in cases of invasive ductal carcinoma (IDC). Large alveolar structures were detected in the infiltrating mixed carcinoma (IMC) and invasive ductal carcinoma (IDC) subtypes of breast cancer (61% and 36%, respectively). The frequency of small-alveolar structures increased statistical significantly in the order IDC > IMC > ILC. Cribriform structures were observed only in the IDC subtype of breast cancer, while small-acinar structures were observed in specimens of the ILC and IMC subtypes of breast cancer.The mean values of the semi-quantitative evaluation of microscopic parameters characterizing the inflammatory infiltration of the stromal component of a breast cancer tumor node, depending on its histological structure, were as follows (Tab. 1).Table 1. Characteristics of infiltrating breast cancer microscopic parameters, (M±g, m)  |
| |
|
Solid-alveolar structures in the tumor parenchyma were 2.5 times more common in the mixed type of breast cancer than in its lobular type (2.58 ± 0.56 compared with 1.04 ± 0.92) (Tab. 2).Table 2. Features of necrotic processes in the parenchyma of a breast cancer tumor nodule, depending on its histological subtype, (M±g, m)  |
| |
|
The grade of malignancy was not associated with the size of the primary tumor node in either the group of patients with preserved menstrual function or in postmenopausal patients, regardless of whether they had received preoperative treatment. In the primary tumor, the structure of the infiltrative component was analyzed in detail, revealing microalveolar, trabecular, tubular, and solid structures, as well as small clusters of tumor cells (Fig. 1).  | Figure 1. Microalveolar structures in the infiltrative component of infiltrating ductal breast cancer. The stroma is mildly fibrous, with marked inflammatory infiltration. Stained with hematoxylin and eosin |
The microalveolar structures consisted of clusters of tumor cells that were either round or slightly irregular in shape but resembling a round shape. The morphological structure of the cells forming this type of structures ranged from small cells with moderately pronounced cytoplasm and round nuclei to large cells with hyperchromatic, irregularly shaped nuclei and moderate cytoplasm. The trabecular structures were either short, consisting of a single row of small, fairly monomorphic cells, or wide, consisting of 2–3 rows of medium-sized cells with moderately pronounced cytoplasm and round, normochromic or hyperchromic nuclei. The tubular structures were formed by a single layer of fairly monomorphic cells with normochromatic, rounded nuclei. The solid structures varied in size and consisted either of small cells with moderately pronounced cytoplasm and monomorphic nuclei or of large cells with abundant cytoplasm and polymorphic nuclei. The cell groups consisted of either single cells or clusters of 1–4 cells that varied in their morphological structure. In most cases, the infiltrative component had a mixed structure. In the group without preoperative treatment, the prevalence of microalveolar structures was not associated with menstrual function (χ² = 0.7; p = 0.41), whereas in the group of patients who received neoadjuvant chemotherapy (NACT), microalveolar structures in the infiltrative component were more frequently detected in postmenopausal patients.The presence of microalveolar structures in the infiltrative component was assessed using a three-point scale, where 1 point was assigned to cases with up to 10% microalveolar structures, 2 points - to cases with >10%–<75% microalveolar structures, and 3 points - to cases with >75%. In the group that did not receive preoperative treatment, neither the severity of microalveolar structures in the infiltrative component nor their presence depended on the status of menstrual function. Trabecular, tubular, and solid structures were observed with equal frequency in patients with different menstrual function statuses in both the group without NACT and the group with NACT (respectively: trabecular χ² = 0.07; p = 0.78 and %² = 0.3; p = 0.59; tubular: %² = 2.4; p = 0.12 and £ = 0.64; p = 0.42; solid: χ² = 0.7; p = 0.38 and %² = 1.7; p = 0.20). In patients who did not receive preoperative chemotherapy, the frequency of cell types in the infiltrative component was approximately the same in both patients with preserved menstrual function and postmenopausal patients (χ² = 0.04; p = 0.83). In the group of patients with NACT, cases in which the infiltrative component consisted of clusters of cells were more frequently observed in patients with preserved menstrual function.
4. Conclusions
Thus, it can be concluded that the IDC subtype of breast cancer is characterized, based on its microscopic features, by a statistically significantly higher grade of malignancy, higher mitotic activity of tumor cells, a higher degree of inflammatory infiltration of the stromal component, and the presence of cribriform structures and necrotic processes in the parenchyma. The ILC subtype of breast cancer, unlike the IDC subtype, is characterized by marked stromal hyalinosis and infiltration of adipose tissue, a predominance of trabecular structures in the parenchyma, and the presence of “dark” cells.
Conflict of Interests’ Statement
The authors declare no conflict of interest. This study does not include the involvement of any budgetary, grant or other funds. The article is published for the first time and is part of a scientific work.
ACKNOWLEDGEMENTS
The authors express their gratitude to the management of the multidisciplinary clinic of Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology for the material provided for our study.
Ethical Approval and Consent to Participate
The Research Ethics Board of our institution does not require review or approval of case reports. Our research was carried out in accordance with the World Medical Association Code of Ethics (Declaration of Helsinki).
References
| [1] | Avtandilov, G.G. Diagnostic Medical Morphometry / G.G. Avtandilov. — Moscow: RMAPO, 2002. — pp. 4–24. |
| [2] | Gong, Y. Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: Agene-expression profiling study / Y. Gong, K. Yan, F. Lin // Lancet Oncol. 2007; 8: 312-315. |
| [3] | Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: Agene-expression profiling study / Gong Y. [et al.] // Lancet Oncol. 2007; 8. |
| [4] | Baak, Jan P.A. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers / Jan P.A. Baak, C. Colpaert, P. J. van Diest // European Journal of Cancer. 2005 September; 41(14): 2093¬2101. |
| [5] | Bräutigam, E. Medial tumor localization in breast cancer—an unappreciated risk factor? / E. Bräutigam, C. Track, D. H. Seewald // Strahlenther Onkol. 2009 0ct; 185(10): 663-668. |
| [6] | Ivanov, V.G. Epidemiological risk factors and early diagnosis of breast cancer / V.G. Ivanov // Practical Oncology. – 2002. – Vol. 3, No. 1. – pp. 1–5. E. Gurevich // Bulletin of Experimental Biology. – 2004. – Vol. 137. – pp. 182–185. |
| [7] | Colpaert, C. Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients / C. Colpaert, P. Vermeulen, P. van Beest, P. Goovaerts // Histopathology 2001 Oct; 39(4): 416-425. |
| [8] | Howell, S. J. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer / S. J. Howell, A. M. Wardley, A. C. Armstrong // J. Nat. Cancer. Inst. 2009 Dec 16; 101(24): 1730. |
| [9] | Genestie, C. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: Major importance of the mitotic count as a component of both grading systems / C. Genestie, B. Zafrani, B. Asselain // Anticancer Res. 1998; 18: 571-576. |
| [10] | Heimann, R. Agiogenesis as a metric of the remote survival for the patients with a node-negative breast cancer / R. Heimann, D. Ferguson, R. R. Weichselbaum // J. Natl. Cancer Inst. - 1996. - № 23. - P. 1764- 1769. |